Birznieks Gunther

Avg. Two Year Performance

No purchase track record
4% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return3%9%9%4%4%
Sale Success Rate5 of 74 of 73 of 72 of 71 of 7

Vanda Pharmaceuticals, Inc.

Drugs » Biotechnology

SVP, Business Development:

Holdings: 313.57K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--